Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer

Cancer Immunology Immunotherapy

Volumn 48, Issue 7, 1999, Pages 396-400

  Yanagawa, Hiroaki ^a   Takeuchi, Eiji ^a   Suzuki, Yoshihiro ^a   Ohmoto, Yasukazu ^a   Bando, Hiroyasu ^b   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Exudative pleural effusion; Interferon ; Lung cancer; Malignant pleurisy; VEGF

Indexed keywords

RECOMBINANT GAMMA INTERFERON; VASCULOTROPIN;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INTRAPLEURAL DRUG ADMINISTRATION; LUNG CANCER; MACROPHAGE FUNCTION; MALE; PATHOPHYSIOLOGY; PLEURA EFFUSION; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; LUNG NEOPLASMS; LYMPHOKINES; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032843886     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050592     Document Type: Article

References (33)

1. Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Khan MA, Jones RT, Harris CC (1998) Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Br J Cancer 78:233
2. Beattie GJ, Smyth JF (1998) Phase I trial of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites. Clin Cancer Res 4:1899
3. Berse B, Brown LF, Van De Walter L, Dvorak HF, Senger DR (1992) Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211
4. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR (1993) Increased expression of vascular permeability factor and its receptors in kidney and bladder carcinomas. Am J Pathol 143:1255
5. Carr DT, Power MH (1958) Clinical value of measurements of concentration of protein in pleural fluid. N Engl J Med 259:926
6. Colotta F, Peri G, Villa A, Mantovani A (1984) Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. J Immunol 132:936
7. Dvorak HF, Nagy JA, Berse B, Brown LF, Yeo KT, Yeo TK, Dvorak AM, Van De Water L, Sioussat TM, Senger DR (1992) Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann NY Acad Sci 667:101
8. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341
9. Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851
10. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL (1997) Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol 157:2329
11. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent. J Natl Cancer Inst 82:4
12. Folkman J (1995) Clinical applications of research on angiogenesis. N Engl J Med 333:1757
13. Fontanini G, Vignati S, Boldrini L, Chine S, Silvesti V, Lucchi M, Mussi A, Angeletti CA, Bevilacqua G (1997) Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 3:861
14. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806
15. Johnston WW (1985) The malignant pleural effusion: a review of cytopathologic diagnosis of 584 specimens from 472 consecutive patients. Cancer 56:905
16. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625
17. Lewis CE, Leek R, Harris A, McGee JO'D (1995) Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 57:747
18. Light RW (1995) Physiology of the pleural space. In: Light RW (ed) Pleural diseases, 3rd ed. Williams & Wilkins, Baltimore, p 7
19. Light RW, MacGregor MI, Luchsinger PC, Ball WC (1972) Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 77:507
20. Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini RN (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor-α and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41:1258
21. Parsons SL, Watson SA, Steele JC (1997) Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites. Eur J Surg Oncol 23:526
22. Pettersson T, Riska H (1981) Diagnostic value of total and differential leukocyte counts in pleural effusions. Acta Med Scand 210:129
23. Ryuto M, Ono M, Izumi H, Yoshida S, Welch HA, Kohno K, Kuwano M (1996) Induction of vascular endothelial growth factor by tumor necrosis factor α in human glioma cells. Possible roles of SP-1. J Biol Chem 271:28220
24. Senger DR, Galli SJ, Dvorak AM, Peruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983
25. Senger DR, Perruzzi CA, Feder J, Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629
26. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor (KDR) correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964
27. Takigawa N, Segawa Y, Fujimoto N, Hotta K, Eguchi K (1998) Elevated vascular endothelial growth factor levels in sera of patients with lung cancer. Anticancer Res 18:1251
28. Tsao MS, Liu N, Nicklee T, Shepherd F, Viallet J (1997) Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma. Clin Cancer Res 3:1807
29. Volm M, Koomägi R, Mattern J (1997) Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 74:64
30. Yanagawa H, Sone S, Munekata M, Atagi S, Ogura T (1992) Identification of interleukin-6 in malignant pleural effusions and its augmentation by intrapleural instillation of interleukin-2. Clin Exp Immunol 88:207
31. Yanagawa H, Yano S, Haku T, Ohmoto Y, Sone S (1996) Interluekin-1 receptor antagonist in pleural effusion due to inflammatory and malignant lung disease. Eur Respir J9:1211
32. Yanagawa H, Haku T, Hiramatsu K, Nokihara H, Takeuchi E, Yano S, Hanibuchi M, Sone S (1997) Intrapleural instillation of interferon γ in patients with malignant pleurisy due to lung cancer. Cancer Immunol Immunother 45:93
33. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewelf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, Yeo TK (1993) Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53:291